A. Elorza

发表

Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn’s disease

J. Gisbert, U. Aguirre, M. Piqueras, 2020, United European gastroenterology journal.

Tacrolimus induces short‐term but not long‐term clinical response in inflammatory bowel disease

J. Gisbert, U. Aguirre, C. Taxonera, 2020, Alimentary pharmacology & therapeutics.

Characteristics and Prognosis of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic in the Basque Country (Spain)

O. Merino, J. Cabriada, I. Rodríguez-Lago, 2020, Gastroenterology.

Usefulness of magnetic resonance enterography in the clinical decision-making process for patients with inflammatory bowel disease

D. Eiroa, J. Cabriada, M. Vela, 2020, Gastroenterología y Hepatología (English Edition).

Usefulness of magnetic resonance enterography in the clinical decision-making process for patients with inflammatory bowel disease.

D. Eiroa, J. Cabriada, M. Vela, 2020, Gastroenterologia y hepatologia.

Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU

J. Gisbert, X. Calvet, M. Piqueras, 2021, American Journal of Gastroenterology.

Gastrointestinal infection with Aeromonas: incidence and relationship to inflammatory bowel disease

U. Aguirre, P. Martínez, J. Cabriada, 2020 .

The impact of vedolizumab and ustekinumab on articular extra-intestinal manifestations in inflammatory bowel disease patients: a real-life multicentric cohort study.

M. De Vos, G. Gonzales, T. Lobaton, 2022, Journal of Crohn's & colitis.

Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU

J. Gisbert, X. Calvet, M. Piqueras, 2022, The American journal of gastroenterology.